• English
  • Eesti


    Printer-friendly version

    The Heads of Medicines Agencies (HMA) is a network of the heads of the National Competent Authorities (NCA) whose organisations are responsible for the regulation of medicinal products for human and veterinary use in the European Economic Area.

    Surveillance over medicinal products in Europe is built on the principle that there are a number of obligations which are the responsibility of each state, and a set of procedures that are carried out centrally, mainly at the European Medicines Agency (EMA). For the purpose of performing national obligations, national competent authorities (NCA) have been designated in all states.

    The HMA co-operates with the European Medicines Agency (EMA) and the European Commission for operating the European Medicines Regulatory Network, and it is a unique model for cooperation and work-sharing in terms of statutory as well as voluntary regulatory activities. More than 20 working groups have been set up within the HMA network to address specific topics. Participation in these working groups is open to the staff of medicines agencies of all Member States.

    The HMA is coordinated and supervised by a Management Group and supported by several Working Groups covering specific areas of responsibility, and by a Permanent Secretariat

    The cooperation network enjoys fixed rules, partners, continuity, its own website, specific objectives and a commonly agreed strategy, vision and mission.

    The first HMA meeting took place in 1996 in Amsterdam. Estonia started attending these meetings following our accession to the European Union in 2004.